{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:46:13Z","timestamp":1791121573238,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.exer.2004.04.008","type":"journal-article","created":{"date-parts":[[2004,6,16]],"date-time":"2004-06-16T11:57:17Z","timestamp":1087387037000},"page":"275-285","source":"Crossref","is-referenced-by-count":52,"title":["Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization"],"prefix":"10.1016","volume":"79","author":[{"given":"Marisol R.","family":"Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Edelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2004.04.008_BIB1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0002-9394(14)75794-0","article-title":"Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy","volume":"118","author":"Adamis","year":"1994","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2004.04.008_BIB2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archopht.1996.01100130062010","article-title":"Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate","volume":"114","author":"Adamis","year":"1996","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2004.04.008_BIB3","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.exer.2004.04.008_BIB4","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1073\/pnas.92.23.10457","article-title":"Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins","volume":"92","author":"Aiello","year":"1995","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"10.1016\/j.exer.2004.04.008_BIB5","first-page":"1561","article-title":"Quantitative MR imaging study of intraviteral sustained release of VEGF in rabbits","volume":"41","author":"Alikacem","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2004.04.008_BIB6","first-page":"18","article-title":"Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization","volume":"39","author":"Amano","year":"1998","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2004.04.008_BIB7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0014-2999(02)02793-0","article-title":"Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model","volume":"458","author":"Ayalasomayajula","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.exer.2004.04.008_BIB8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/sj.gt.3301680","article-title":"Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1","volume":"9","author":"Bainbridge","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.exer.2004.04.008_BIB9","first-page":"940","article-title":"Cholera toxin induces prostaglandin synthesis via post-transcriptional activation of cyclooxygenase-2 in the rat jejunum","volume":"297","author":"Beubler","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.exer.2004.04.008_BIB10","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.2460\/ajvr.2001.62.1755","article-title":"In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats","volume":"62","author":"Brideau","year":"2001","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.exer.2004.04.008_BIB11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1023\/A:1022364731126","article-title":"Measurement of cyclooxygenase inhibition in vivo: a study of two non-steroidal anti-inflammatory drugs in sheep","volume":"22","author":"Cheng","year":"1998","journal-title":"Inflammation"},{"key":"10.1016\/j.exer.2004.04.008_BIB12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1476-5381.1993.tb13553.x","article-title":"Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo","volume":"109","author":"Collins","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.exer.2004.04.008_BIB13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00003226-200007000-00025","article-title":"Immunohistochemical localization of vascular endothelial growth factor, transforming growth factor alpha, and transforming growth factor beta1 in human corneas with neovascularization","volume":"19","author":"Cursiefen","year":"2000","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2004.04.008_BIB14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s004320000225","article-title":"Cyclooxygenase-2: a novel target for cancer chemotherapy?","volume":"127","author":"Dempke","year":"2001","journal-title":"J. Cancer. Res. Clin. Oncol."},{"key":"10.1016\/j.exer.2004.04.008_BIB15","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1172\/JCI200111334","article-title":"Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo","volume":"108","author":"Dowd","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.exer.2004.04.008_BIB16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1006\/exer.2000.0907","article-title":"Quantitative image analysis of laser-induced choroidal neovascularization in rat","volume":"71","author":"Edelman","year":"2000","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2004.04.008_BIB17","first-page":"1112","article-title":"Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea","volume":"40","author":"Edelman","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2004.04.008_BIB18","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/sj.bjp.0703941","article-title":"Vascular endothelial growth factor and the in vivo increase in plasma extravasation in the hamster cheek pouch","volume":"132","author":"Feletou","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.exer.2004.04.008_BIB19","first-page":"325","article-title":"Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis","volume":"31","author":"Fosslien","year":"2001","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.exer.2004.04.008_BIB20","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/PL00005079","article-title":"Role of nitric oxide, prostaglandins and tyrosine kinase in vascular endothelial growth factor-induced increase in vascular permeability in mouse skin","volume":"356","author":"Fujii","year":"1997","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.exer.2004.04.008_BIB21","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s000110050232","article-title":"Selective inhibition of cyclooxygenase-2 by NS-398 in endotoxin shock rats in vivo","volume":"46","author":"Futaki","year":"1997","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.exer.2004.04.008_BIB22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/104303403321070829","article-title":"Periocular Gene Transfer of sFlt-1 Suppresses Ocular Neovascularization and vascular endothelial growth factor-induced breakdown of the blood\u2013retinal barrier","volume":"14","author":"Gehlbach","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.exer.2004.04.008_BIB23","first-page":"1588","article-title":"Effect of inhibitors of arachidonic acid metabolism on corneal neovascularization in the rat","volume":"30","author":"Haynes","year":"1989","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2004.04.008_BIB24","doi-asserted-by":"crossref","first-page":"25130","DOI":"10.1074\/jbc.274.35.25130","article-title":"Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1\/KDR activation of c-Src","volume":"274","author":"He","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2004.04.008_BIB25","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1006\/bbrc.1999.1729","article-title":"A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF\u2014a stimulation in endothelial cells","volume":"265","author":"Kroll","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exer.2004.04.008_BIB26","first-page":"1929","article-title":"Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor","volume":"37","author":"Kvanta","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2004.04.008_BIB27","first-page":"3158","article-title":"VEGF is major stimulator in model of choroidal neovascularization","volume":"41","author":"Kwak","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2004.04.008_BIB28","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1089\/104303401750270959","article-title":"Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization","volume":"12","author":"Lai","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.exer.2004.04.008_BIB29","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1023\/A:1006728119549","article-title":"Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line","volume":"17","author":"Liu","year":"1999","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.exer.2004.04.008_BIB30","first-page":"855","article-title":"Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes","volume":"37","author":"Lopez","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2004.04.008_BIB31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/(SICI)1097-4547(19970801)49:3<268::AID-JNR2>3.0.CO;2-A","article-title":"Blood\u2013retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1 beta-mediated breakdown","volume":"49","author":"Luna","year":"1997","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.exer.2004.04.008_BIB32","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1073\/pnas.91.8.3228","article-title":"Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic","volume":"91","author":"Masferrer","year":"1994","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"10.1016\/j.exer.2004.04.008_BIB33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2460\/ajvr.2001.62.54","article-title":"Effects of anti-inflammatory drugs on lipopolysaccharide-challenged and -unchallenged equine synovial explants","volume":"62","author":"Moses","year":"2001","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.exer.2004.04.008_BIB34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/01.CIR.97.1.99","article-title":"Vascular endothelial growth factor\/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin","volume":"97","author":"Murohara","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.exer.2004.04.008_BIB35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1006\/exer.1996.0239","article-title":"Intravitreal sustained release of VEGF causes retinal neovacularization in rabbits and breakdown of the blood\u2013retinal barrier in rabbits and primates","volume":"64","author":"Ozaki","year":"1997","journal-title":"Exp. Eye. Res."},{"key":"10.1016\/j.exer.2004.04.008_BIB36","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0002-9440(10)64773-6","article-title":"Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization","volume":"156","author":"Ozaki","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2004.04.008_BIB37","first-page":"2514","article-title":"Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas","volume":"41","author":"Philipp","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2004.04.008_BIB38","first-page":"2408","article-title":"VEGF-initiated blood\u2013retinal barrier breakdown in early diabetes","volume":"42","author":"Qaum","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2004.04.008_BIB39","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1139\/y97-130","article-title":"Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays","volume":"75","author":"Riendeau","year":"1997","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.exer.2004.04.008_BIB40","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jcp.10246","article-title":"VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood\u2013retinal barrier","volume":"195","author":"Saishin","year":"2003","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.exer.2004.04.008_BIB41","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1001\/archopht.1995.01100020106040","article-title":"Effect of intravitreal administration of indomethacin on experimental subretinal neovascularization in the subhuman primate","volume":"113","author":"Sakamoto","year":"1995","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2004.04.008_BIB42","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0002-9440(10)65430-2","article-title":"Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor","volume":"154","author":"Seo","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2004.04.008_BIB44","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1046\/j.1460-9568.2000.00263.x","article-title":"Induction of VEGF and VEGF receptors in the spinal cord after mechanical spinal injury and prostaglandin administration","volume":"12","author":"Skold","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.exer.2004.04.008_BIB45","doi-asserted-by":"crossref","first-page":"13313","DOI":"10.1073\/pnas.95.22.13313","article-title":"Pharmacological analysis of cyclooxygenase-1 in inflammation","volume":"95","author":"Smith","year":"1998","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"10.1016\/j.exer.2004.04.008_BIB46","first-page":"1975","article-title":"Rapid ocular angiogenic control via naked DNA delivery to cornea","volume":"42","author":"Stechschulte","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2004.04.008_BIB47","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3928\/1081-597X-19931101-07","article-title":"Topical diclofenac treatment prior to excimer laser photorefractive keratectomy in rabbits","volume":"9","author":"Szerenyi","year":"1993","journal-title":"Refract. Corneal Surg."},{"key":"10.1016\/j.exer.2004.04.008_BIB48","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1167\/iovs.02-0346","article-title":"Topical nepafenac inhibits ocular neovascularization","volume":"44","author":"Takahashi","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2004.04.008_BIB49","first-page":"459","article-title":"Suppression of laser-induced choroidal neovascularization by oral tranilast in the rat","volume":"40","author":"Takehana","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2004.04.008_BIB50","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1046\/j.1471-4159.2001.00613.x","article-title":"Effects of selective COX-1 and -2 inhibition on formalin-evoked nociceptive behaviour and prostaglandin E2 release in the spinal cord","volume":"79","author":"Tegeder","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.exer.2004.04.008_BIB52","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1167\/iovs.02-0392","article-title":"COX-2 inhibition and retinal angiogenesis in a mouse model of retinopathy of prematurity","volume":"44","author":"Wilkinson-Berka","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2004.04.008_BIB53","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1076\/ceyr.22.2.140.5528","article-title":"Intravitreal VEGF and bFGF produce florid retinal neovascularization and hemorrhage in the rabbit","volume":"22","author":"Wong","year":"2001","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2004.04.008_BIB54","first-page":"H2735","article-title":"VEGF induces NO-dependent hyperpermeability in coronary venules","volume":"271","author":"Wu","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.exer.2004.04.008_BIB55","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1076\/ceyr.19.4.300.5301","article-title":"The effect of selective cyclooxygenase-2 inhibitor on corneal angiogenesis in the rat","volume":"19","author":"Yamada","year":"1999","journal-title":"Curr. Eye Res."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483504001344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483504001344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T10:37:06Z","timestamp":1624444626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483504001344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0014483504001344"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2004.04.008","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}